ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.341,13
0,74%
S&P 500
5.464,62
-0,16%
US Dollar vs BRL
5,4321
-0,20%
Bitcoin
64.034,10
-0,33%
Brent Oil
84,39
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. La Jolla Pharmaceutical Company (LJPC)

  7. La Jolla Pharmaceutical Company (LJPC) Notícias

LJPC

La Jolla Pharmaceutical (LJPC)

La Jolla Pharmaceutical Company
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LJPC
DataHoraFonteTítuloCódigoCompanhia
14/02/202312:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
01/09/202209:39Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LJPCLa Jolla Pharmaceutical Company
29/08/202213:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
29/08/202213:10Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:LJPCLa Jolla Pharmaceutical Company
23/08/202218:01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202210:32Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202210:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202210:20Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202210:09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
22/08/202209:55Business WireInnoviva Completes Acquisition of La Jolla PharmaceuticalNASDAQ:LJPCLa Jolla Pharmaceutical Company
15/08/202209:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LJPCLa Jolla Pharmaceutical Company
25/07/202209:40Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LJPCLa Jolla Pharmaceutical Company
25/07/202209:35Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LJPCLa Jolla Pharmaceutical Company
12/07/202207:10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:LJPCLa Jolla Pharmaceutical Company
11/07/202216:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LJPCLa Jolla Pharmaceutical Company
11/07/202208:32Business WireInnoviva to Acquire La Jolla Pharmaceutical CompanyNASDAQ:LJPCLa Jolla Pharmaceutical Company
05/07/202218:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LJPCLa Jolla Pharmaceutical Company
16/05/202217:15Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
09/03/202210:15Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
09/03/202210:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:LJPCLa Jolla Pharmaceutical Company
17/11/202110:00Business WireLa Jolla Pharmaceutical Company Announces Share Repurchase PlanNASDAQ:LJPCLa Jolla Pharmaceutical Company
04/11/202109:45Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
02/11/202110:14Edgar (US Regulatory)Notification That a Class of Securities of Successor Issuer Is Demed to Be Registered Pursuant to Section 12(b) (8-k12b)NASDAQ:LJPCLa Jolla Pharmaceutical Company
10/09/202109:00Business WireTony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical CompanyNASDAQ:LJPCLa Jolla Pharmaceutical Company
05/08/202109:30Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Corporate ProgressNASDAQ:LJPCLa Jolla Pharmaceutical Company
04/06/202108:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
04/06/202108:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
25/05/202118:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:LJPCLa Jolla Pharmaceutical Company
07/05/202109:45Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 & Highlights Corporate ...NASDAQ:LJPCLa Jolla Pharmaceutical Company
08/03/202110:55Business WireLa Jolla Pharmaceutical Company Announces Financial Results for the Three & Twelve Months Ended December 31, 2020 & Highlight...NASDAQ:LJPCLa Jolla Pharmaceutical Company
 Apresentando as notícias mais relevantes sobre:NASDAQ:LJPC

Seu Histórico Recente

LSE
47TJ
Res Mtg 13 Nt26
XE
KWS
KWS SAAT SE & Co KGaA
NASDAQI
SX5010PI
OMX Stockholm Constructi...
LSE
0Q5A
Navios Maritime Partners
TG
A282HM
CPI Property
BIT
P1Z1V6
NLBNPIT1Z1V6 20991231 14...
USOTC
ALTUF
Altus Strategies (QX)
BIT
UB22G6
UniCredit Bank
COIN
CHIRPETH
Chirp
LSE
MF85
Newday Fmi 30 S
LSE
73LT
Cap. Hosp B 46
BITMOT
2888791
Ebrd Zc Mar34 Call Try
COIN
SWAPBTC
NYSE
ALL-J
Allstate
BIT
P1S1J0
NLBNPIT1S1J0 20240621 350
LSE
93VV
Newday 27 S
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados